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Abstract
Background: Systemic sclerosis (SSc) is a rheumatologic disease with a multifactorial etiology. Genome-wide
association studies imply a polygenic, complex mode of inheritance with contributions from variation at the
human leukocyte antigen locus and non-coding variation at a locus on chromosome 6p21, among other modestly
impactful loci. Here we describe an 8-year-old female proband presenting with diffuse cutaneous SSc/scleroderma
and a family history of SSc in a grandfather and maternal aunt.
Methods: We employed whole exome sequencing (WES) of three members of this family. We examined rare
missense, nonsense, splice-altering, and coding indels matching an autosomal dominant inheritance model.
We selected one missense variant for Sanger sequencing confirmation based on its predicted impact on gene
function and location in a known SSc genetic locus.
Results: Bioinformatic analysis found eight candidate variants meeting our criteria. We identified a very rare missense
variant in the regulatory NODP domain of NOTCH4 located at the 6p21 locus, c.4245G > A:p.Met1415Ile, segregating
with the phenotype. This allele has a frequency of 1.83 × 10−5 by the data of the Exome Aggregation Consortium.
Conclusion: This family suggests a novel mechanism of SSc pathogenesis in which a rare and penetrant coding
variation can substantially elevate disease risk in contrast to the more modest non-coding variation typically found at
this locus. These results suggest that modulation of the NOTCH4 gene might be responsible for the association signal
at chromosome 6p21 in SSc.
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Background
Systemic sclerosis, also known as SSc or scleroderma, is
an autoimmune disease characterized by a triad of micro-
vascular dysfunction, immune dysfunction, and general-
ized fibrosis in connective tissues and organs [1]. One of
the most concerning aspects of the disease is that mortal-
ity has not improved greatly over the last several decades
because there is a critical lack of therapies to address the
fibrotic process [2]. The urgent need for innovation in SSc
is one of the motivations of the genetics community in
attempting to explore the hereditary underpinnings of this
condition. Genetic epidemiology has shown convincing
evidence of familial aggregation, with increased risk to
siblings and first degree relatives as well as substantial
epidemiologic overlap with other autoimmune diseases
[3]. The etiology of the disease is multifactorial, with
poorly-understood environmental influences and a com-
plex mode of genetic inheritance. Since SSc is a relatively
rare disease, most cases appear sporadically, without fam-
ily history [3]. Recent advances in genomic technology,
such as high-density genotyping on microarrays, have
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made possible genome-wide association studies (GWAS)
that have enhanced the genetic understanding of SSc.
The single stand-out genetic risk for SSc is associated
with an array of variants in the major histocompatibility
complex (MHC), containing the human leukocyte anti-
gen (HLA) genes [4], a pattern seen in a wide array of
autoimmune diseases. The first large GWAS revealed
associations with non-coding SNPs at a number of loci
in addition to the HLA, including IRF5, STAT4, CD247,
CDH7, and IRF4 [4]. Later GWAS on specific biomarkers
and clinical phenotypes [5] as well as high-density geno-
typing in selected regions on the Immunochip [6] have
yielded additional associations. A recent study used whole
exome sequencing (WES) in a modest number of
cases to identify specifically protein-altering variants,
revealing a low-frequency variant in ATP8B4 which
was enriched among SSc cases compared to controls
(odds ratio = 6.1) [7].
Of particular interest is an association from GWAS
with the NOTCH4 locus which lies on chromosome
6p21 in proximity to the HLA region. This locus gave an
association with the presence of anti-centromere anti-
body (ACA) or anti-topoisomerase I antibody (ATA) in
SSc with P < 8.84 × 10−21, OR = 0.55 which were independ-
ent of the HLA class II associations [5]. The NOTCH4
locus has previously been associated, independently
from the HLA, with other autoimmune disorders in-
cluding ulcerative colitis [8], rheumatoid arthritis [9],
and alopecia areata [10] and age-related macular degener-
ation [11].
NOTCH4 is a member of a four-gene family (NOTCH1
to 4) and is expressed specifically in endothelial cells [12].
NOTCH proteins are transmembrane receptors activated
by transmembrane ligands of the DSL family (Delta/
Serrate/Lag-2). Based on structural investigation of
the well-studied NOTCH1 family member, binding of
the ligand triggers a conformational change in the
negative regulatory region (NRR), consisting of LNR
repeats and a heterodimerization (HD) region consisting
of a NOD and a NODP domain (NOTCH domain)
[13, 14]. The isomerization of the NRR unmasks protease
cleavage sites, which leads to the intracellular domain of
the NOTCH1 receptor being cleaved off. The free intra-
cellular domain translocates to the nucleus and binds to
the DNA-binding transcription factor RBP-Jk, activating
transcription (Fig. 1).
There are multiple phenotypic manifestations caused
by the activation of NOTCH4 in a mouse model system.
Ectopic overexpression of the free NOTCH4 intracellu-
lar domain in mammary epithelium leads to oncogenic
transformation and mammary carcinogenesis [14, 15].
Expression of the free intracellular domain in vascular
endothelium is embryonic lethal, with disorganized vas-
cular networks, fewer small vessels, and compromised
vessel-wall integrity, demonstrating an important role
for NOTCH4 signaling in the development of the vascu-
lar system [16]. The role of NOTCH4 in vascular devel-
opment has significant implications for SSc because the
pathological process is thought to be driven by damage
to the microvasculature caused by dysfunctional endo-
thelial cells. Morphological changes and activation of
endothelial cells are often the earliest detectable sign of
disease [17]. This vascular damage leads to reduction in
the number of small vessels, thickening of the vessel
wall, and luminal narrowing, eventually leading to tissue
hypoxia [17]. The connection between vasculopathy and
fibrosis is unclear but is under investigation.
Here we describe a family presenting with a three-
generation history of SSc in an apparently autosomal-
dominant mode of inheritance. We used whole exome
sequencing to identify rare mutations which segregate as
expected in the pedigree and which might be contributory
to the development of the disease. Our characterization of
a very rare missense variant in the NOTCH4 NODP
domain is described below. The NODP domain is of
particular interest because in the homologous NOTCH1
receptor, mutations in this domain result in constitu-
tive activation and consequent T cell acute lymphoblastic
leukemia [18].
Methods
Whole exome sequence analysis
The SSc phenotype of the proband was determined by a
senior pediatric rheumatologist and family history was
confirmed.
After written informed consent was obtained, genomic
DNA was extracted from the peripheral blood lympho-
cytes of the proband, mother, affected maternal aunt,
unaffected maternal uncle and unaffected maternal
grandmother. Whole exome capture was carried out for
the two patients and unaffected maternal grandmother
using the SureSelect Human All Exon version 3 kit
(Agilent Technologies, Santa Clara, CA), according to
the manufacturer’s protocols. Sequencing was carried
out on the HiSeq 2000 instrument (Illumina, San Diego,
CA) using the manufacturer’s recommended procedure.
Mapping of next generation sequencing reads and vari-
ant calling was performed with the Burrows-Wheeler
aligner (BWA) [19] and the variants called using the
Genome Analysis Toolkit (GATK) [20]. The results were
filtered to exclude synonymous variants, variants with
minor allele frequency greater than 0.5 % under an auto-
somal dominant model, and variants previously identi-
fied in controls by our in-house exome variant database
using ANNOVAR [21]. ANNOVAR produced the data
in Additional file 1: Table S1, including functional im-
pact scores (SIFT [22], PolyPhen2 [23], and GERP [24]).
The kinship coefficient was calculated between every
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two samples via KING to confirm reported relationships
[25]. Co-segregation patterns were confirmed by Sanger
sequencing in 5 members whose DNA was available
using standard PCR amplicons.
Results
Clinical history
We encountered an 8-year-old female proband with SSc
and a positive family history, which included a maternal
grandfather who died of SSc and a maternal aunt with
limited SSc (Fig. 2). The proband presented with severe
Raynaud’s with dilated nailfold capillaries, capillary drop-
out, digital ulceration, digital scarring, and skin tighten-
ing over her face, arms, and legs. The patient displayed
scleroderma facies with tightening of the skin around
the eyes and lips with associated pallor. She did not
show signs of organ fibrosis as shown by chest CT and
echocardiogram. There were no signs of joint pain,
swelling, stiffness, gastrointestinal symptoms, or rashes.
A serological panel was performed for a spectrum of
rheumatologic conditions, including ACA and ATA anti-
bodies, which were all negative. These features meet the
2013 ACR/EULAR criteria for the classification of SSc
[26]. Due to the very early onset of disease in this
proband and the presence of a three-generation family
history, we suspected a risk contribution from a rare
variant of incomplete penetrance segregating in this
family in an autosomal-dominant pattern. Consequently,
we collected DNA specimens from five members of this
family (Fig. 2) and we sequenced the exome in three
individuals.
Exome analysis
As described in the Methods, exomes underwent bio-
informatic filtering to select protein-altering variants
that fit the specified autosomal dominant inheritance
model and which were rare, defined as less than 0.5 %
for minor allele frequency. Variants meeting these cri-
teria are itemized in Additional file 1: Table S1. The
NOTCH4 c.4245G > A:p.Met1415Ile variant has a Sort-
ing Intolerance from Tolerance (SIFT) score of 0.02,
which is predicted to be deleterious. Notably, the Exome
Aggregation Consortium (http://exac.broadinstitute.org/
variant/6-32168678-C-T) shows two heterozygous indi-
viduals out of 109,358 alleles for an allele frequency of
1.83 × 10−5, an extremely rare variant.
Fig. 1 An overview of proposed NOTCH4 structure and signaling. a The receptor NOTCH4 is a 2002-amino acid transmembrane protein with its
N terminus situated extracellularly (Type I membrane protein). From N terminus to C terminus it consists of 36 epidermal growth factor (EGF)
repeats; 3 NOTCH domains (LNR, Lin-12/Notch repeat); a heterodimerization domain (HD) containing the NODP domain; a transmembrane
domain (TM); and an intracellular domain. The intracellular domain is made up of ankyrin repeats (ANK) and a PEST domain. b The mechanism of
NOTCH family signaling involves binding by a ligand of the DSL family (e.g., DLL4), which results in cleavage of the intracellular domain at the
plasma membrane. The intracellular domain translocates to the nucleus where it binds DNA-binding transcription factor RBP-Jk and acts as a
transcriptional activator of effector gene transcription such as HES1 and HEY1
Cardinale et al. BMC Musculoskeletal Disorders  (2016) 17:462 Page 3 of 6
The next-generation sequencing results were vali-
dated by automated fluorescent Sanger sequencing
(Fig. 2) and transmission in the predicted individuals
was confirmed.
Discussion
NOTCH4 is expressed almost exclusively in the endo-
thelium and is thought to play an important role in
the development of the vascular system. Considering
the vascular abnormalities in this patient, the known
contribution of vascular dysfunction in SSc, and the
prior identification of a locus containing NOTCH4 as
a risk factor, we prioritized this variant.
Polymorphisms affecting expression of NOTCH4 have
been implicated in a broad array of autoimmune diseases
independent of their proximity to the HLA locus on
chromosome 6p21. Here we have described a very
rare amino acid substitution in a putative regulatory
region of NOTCH4 segregating in a family with SSc/
scleroderma.
We note that the mother of the proband appears
disease-free despite carrying the exact same NOTCH4
p.Met1415Ile variant and without the expression of
scleroderma. We are proposing that this mutation has
less-than-100 % penetrance, which is frequently the case
in autosomal dominant disease. Generally, the reason for
this incomplete penetrance is not known. An alternative
explanation would be polygenic inheritance, in which a
phenotype arises from the additive interaction of a
multitude of moderately impactful loci and displays a
complex mode of inheritance. Systemic sclerosis/sclero-
derma ordinarily belongs to the polygenic category and
it is associated with a multitude of SNPs which GWAS
of SSc have shown to have effect sizes of OR < 2 outside
the HLA region. This family appears to be a Mendelian
phenocopy of the classic polygenically-inherited SSc be-
cause a very rare disease would be unlikely to occur with
this three-generation history under a complex polygenic
model of inheritance. Nevertheless, we cannot exclude
the possibility that this variant is a false positive since
we only have three affected carriers and the LOD score
would not be expected to be genome-wide significant by
classical linkage study criteria. This result is highly sug-
gestive and is a starting point for functional studies that
would focus on revealing the mechanism of NOTCH4
signaling.
As the least well-studied member of the NOTCH
family, there is evidence that NOTCH4 functions in a
manner unlike its paralogs and affects processes other
than transcription. The results of James et al. suggest a
unique post-translational processing of the receptor,
since they found perinuclear localization of the protein
and lack of proteolytic cleavage to form a heterodimer
[27]. Of note, James et al. were unable to demonstrate
autonomous signaling of the NOTCH4 receptor in HEK
293 cells, even when co-cultured with cells expressing
the DSL family ligand [27].
The goal of functional analysis is further compli-
cated by the fact that Notch4 knockout mice do not
have known phenotypic characteristics [28]. Double-
knockout Notch1/Notch4 mice show a more severe
phenotype than Notch1 knockout alone particularly
with abnormal angiogenic vascular remodeling [28].
However, this family did not carry any rare variants
in NOTCH1.
Fig. 2 A family with systemic sclerosis segregating a mutation in
NOTCH4. a Pedigree of the family under study. There are three
affecteds (filled symbols). Proband is indicated by an arrow. b Sanger
sequencing validation of the NOTCH4 p.Met1415Ile variant. Arrowheads
show the heterozygous C > T mutation in the chromatograms
Cardinale et al. BMC Musculoskeletal Disorders  (2016) 17:462 Page 4 of 6
Conclusion
No pathogenic mutations in the heterodimerization/
NODP domain of NOTCH4 have been reported before.
The genetic evidence from the family described here is
supported by the known impact of NOTCH4 intracellu-
lar domain expression on the vascular endothelium in
mouse models and the role of endothelium in the devel-
opment of SSc. SNP-to-gene assignment in the analysis
of complex traits by GWAS is a serious challenge for the
genetics community. The segregation of this rare variant
across three generations in a family argues that the
variety of non-coding polymorphisms seen in auto-
immune disease at the chromosome 6p21 genomic
locus are affecting expression of the NOTCH4 gene.
We will seek to address the role of this mutation
more definitively through the construction of a
CRISPR knock-in mouse [29] bearing the variant so
that its role in the vasculature and fibrosis can be
assessed. Further evidence supporting the causal role
of this variant should also be obtained in future studies
focused on sequencing additional pedigrees for NOTCH4
mutations.
Additional file
Additional file 1: Table S1. Table of rare coding variants segregating
with the SSc/scleroderma phenotype. (XLS 27 kb)
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